The HCM City Department of Health has asked the Medical Examination and Treatment Administration and the Drug Administration of Vietnam to approve the use of Reamberin and Cytoflavin drugs in the treatment of Covid-19 patients.
A drug bag used to treat Covid-19 patients at home in HCM City.
Nguyen Hoai Nam, Deputy Director of the HCM City Department of Health, said a Russian company - Polysan – wanted to donate Reamberin and Cytoflavin drugs to serve the prevention of Covid-19 epidemic in Ho Chi Minh City.
The HCM City Department of Health said that Reamberin and Cytoflavin are being used in the treatment regimen of Covid-19 patients in Russia. Reamberin is for reducing blood oxygen and detoxification in cases of acute poisoning due to various causes. Cytoflavin is indicated for the prevention of acute ischemic stroke.
The HCM City Department of Health has proposed that the professional council of the Ministry of Health consider adding the two drugs to the treatment regimen for Covid-19 patients so that the city can receive and use the drugs at medical facilities in the area.
Currently, HCM City is using two antiviral drugs to treat Covid-19 patients.
As of 6pm on September 1, the city had 227,129 cases of Covid-19, including 226,681 locally-infected cases, 41,040 patients under treatment, with 2,890 children under 16 years old, 2,749 critically ill patients who need ventilators, and 19 cases of ECMO intervention.
On September 1, 3,369 patients were discharged from the hospital, bringing the total number of recovered patients since January 1 to 116,337.
The Ministry of Health has announced that the antiviral drug molnupiravir will be part of the medicine package provided to COVID-19 patients in HCM City, while three robots will be used to deliver food to patients at a resuscitation hospital.